Christopher Recknor

Teriparatide for acceleration of fracture repair in humans: A prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures

Per Aspenberg, Harry K. Genant, Torsten Johansson et al. · Journal of Bone and Mineral Research · 2009 · 504 citations · Full text

Skeletal Trauma, Animal Experiments, Bone Disease +14

Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial

Clemens Becker, Stephen R. Lord, Stephanie A. Studenski et al. · The Lancet Diabetes & Endocrinology · 2015 · 353 citations

Older Weak Fallers, Autoimmune Disease, Immunology +5

Effects of Teriparatide in Postmenopausal Women with Osteoporosis on Prior Alendronate or Raloxifene: Differences between Stopping and Continuing the Antiresorptive Agent

Felicia Cosman, Robert A. Wermers, Christopher Recknor et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 170 citations

Discontinuation of denosumab and associated fracture incidence: Analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial

Jacques P. Brown, Christian Roux, Ove Törring et al. · Journal of Bone and Mineral Research · 2012 · 144 citations · Full text

Incidence of Osteonecrosis of the Jaw in Women With Postmenopausal Osteoporosis in the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly Pivotal Fracture Trial

John T. Grbic, Regina Landesberg, Shouqing Lin et al. · The Journal of the American Dental Association · 2008 · 138 citations

Bone Disease, Bone Health, Reduced Incidence +9